Buspirone Hydrochloride Tablet
Product Images NDC 71610-959

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-959). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0959 30)

Buspirone HCI tablets are available under the NDC number 71610-950-30. These tablets should be stored in a cool, dry place and kept out of reach of children. If you have any questions about this medication, you may contact the manufacturer at the address provided.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure 1 (Fig 1)

This text provides information on the different dosages that can be obtained by dividing a tablet. It includes dosages of 15 mg, 10 mg, 7.5 mg, and 5 mg, corresponding to one whole tablet, two-thirds of a tablet, one-half of a tablet, and one-third of a tablet respectively. This information can be helpful for individuals needing to take specific dosages of a medication.*

FDA Label Image

Figure 2 (Figure2)

FDA Label Image

Figure 3 (Figure3)

This is a description of different dosages of a tablet, including the amounts for the entire tablet, two-thirds of a tablet, one-half of a tablet, and one-third of a tablet. The tablet comes in 30 mg, 20 mg, 15 mg, and 10 mg strengths, respectively.*

FDA Label Image

Figure 4 (Figure4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.